The role of c‐Myb and Sp1 in the up‐regulation of methionine adenosyltransferase 2A gene expression in human hepatocellular carcinoma

2001 ◽  
Vol 15 (9) ◽  
pp. 1507-1516 ◽  
Author(s):  
Heping Yang ◽  
Zong-Zhi Huang ◽  
Jiaohong Wang ◽  
Shelly C. Lu
Keyword(s):  
Gene Expression ◽  
Hepatocellular Carcinoma ◽  
Human Hepatocellular Carcinoma ◽  
Methionine Adenosyltransferase

Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinoma

2020 ◽  
Vol 47 (10) ◽  
pp. 7429-7437
Author(s):  
Hamzeh Karimkhanloo ◽  
Samira Mohammadi-Yeganeh ◽  
Razie Hadavi ◽  
Ameneh Koochaki ◽  
Mahdi Paryan
Keyword(s):  
Gene Expression ◽  
Hepatocellular Carcinoma ◽  
Potential Role

scholarly journals Distinct molecular etiologies of male and female hepatocellular carcinoma

BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Heini M. Natri ◽  
Melissa A. Wilson ◽  
Kenneth H. Buetow
Keyword(s):  
Gene Expression ◽  
Hepatocellular Carcinoma ◽  
Sex Differences ◽  
Differential Expression ◽  
Differential Expression Analysis ◽  
Regulation Of Transcription ◽  
Male And Female ◽  
Differential Effects ◽  
Pathway Enrichment

Abstract Background Sex-differences in cancer occurrence and mortality are evident across tumor types; men exhibit higher rates of incidence and often poorer responses to treatment. Targeted approaches to the treatment of tumors that account for these sex-differences require the characterization and understanding of the fundamental biological mechanisms that differentiate them. Hepatocellular Carcinoma (HCC) is the second leading cause of cancer death worldwide, with the incidence rapidly rising. HCC exhibits a male-bias in occurrence and mortality, but previous studies have failed to explore the sex-specific dysregulation of gene expression in HCC. Methods Here, we characterize the sex-shared and sex-specific regulatory changes in HCC tumors in the TCGA LIHC cohort using combined and sex-stratified differential expression and eQTL analyses. Results By using a sex-specific differential expression analysis of tumor and tumor-adjacent samples, we uncovered etiologically relevant genes and pathways differentiating male and female HCC. While both sexes exhibited activation of pathways related to apoptosis and cell cycle, males and females differed in the activation of several signaling pathways, with females showing PPAR pathway enrichment while males showed PI3K, PI3K/AKT, FGFR, EGFR, NGF, GF1R, Rap1, DAP12, and IL-2 signaling pathway enrichment. Using eQTL analyses, we discovered germline variants with differential effects on tumor gene expression between the sexes. 24.3% of the discovered eQTLs exhibit differential effects between the sexes, illustrating the substantial role of sex in modifying the effects of eQTLs in HCC. The genes that showed sex-specific dysregulation in tumors and those that harbored a sex-specific eQTL converge in clinically relevant pathways, suggesting that the molecular etiologies of male and female HCC are partially driven by differential genetic effects on gene expression. Conclusions Sex-stratified analyses detect sex-specific molecular etiologies of HCC. Overall, our results provide new insight into the role of inherited genetic regulation of transcription in modulating sex-differences in HCC etiology and provide a framework for future studies on sex-biased cancers.

Sign in / Sign up

Export Citation Format

Share Document